Title: Concomitant use of magnesium oxide significantly decreases absorption of levodopa preparations in patients with Parkinson's disease.
PMID: 38021340

Abstract:
Constipation is one of the most frequent non-motor symptoms of Parkinson's disease (PD), and magnesium oxide (MgO) is a frequently used laxative. This study aimed to investigate the effect of concomitant use of MgO on the pharmacokinetics of levodopa preparations in patients with PD.